As of October 2026 Theravance Biopharma has a market cap of NZ$1.57 Billion. This makes Theravance Biopharma the world's 6513th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.